{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:06:08Z","timestamp":1784653568876,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013949","name":"British Mass Spectrometry Society","doi-asserted-by":"publisher","award":["LISBOA-01-0145-FEDER-022125"],"award-info":[{"award-number":["LISBOA-01-0145-FEDER-022125"]}],"id":[{"id":"10.13039\/100013949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013949","name":"British Mass Spectrometry Society","doi-asserted-by":"publisher","award":["ROTEIRO\/0028\/2013"],"award-info":[{"award-number":["ROTEIRO\/0028\/2013"]}],"id":[{"id":"10.13039\/100013949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/BIO\/04469"],"award-info":[{"award-number":["UID\/BIO\/04469"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000004"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000004"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-006684"],"award-info":[{"award-number":["POCI-01-0145-FEDER-006684"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtn.2019.09.016","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T19:39:55Z","timestamp":1569526795000},"page":"508-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Application of 2\u2032-OMethylRNA\u2032 Antisense Oligomer to Control Candida albicans EFG1 Virulence Determinant"],"prefix":"10.1016","volume":"18","author":[{"given":"Daniela","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno Miguel","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisa","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f3nia","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2019.09.016_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.riam.2018.07.002","article-title":"Epidemiology of invasive mycoses: a landscape in continuous change","volume":"35","author":"Quind\u00f3s","year":"2018","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.omtn.2019.09.016_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","article-title":"Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.omtn.2019.09.016_bib3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/jcla.20337","article-title":"Correlation between Etest, disk diffusion, and microdilution methods for antifungal susceptibility testing of Candida species from infection and colonization","volume":"23","author":"Negri","year":"2009","journal-title":"J.\u00a0Clin. Lab. Anal."},{"key":"10.1016\/j.omtn.2019.09.016_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","article-title":"Epidemiology and risk factors for invasive candidiasis","volume":"10","author":"Yapar","year":"2014","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.omtn.2019.09.016_bib5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","article-title":"Vulvovaginal candidiasis: epidemiology, microbiology and risk factors","volume":"42","author":"Gon\u00e7alves","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.omtn.2019.09.016_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tim.2016.09.004","article-title":"Portrait of Candida species biofilm regulatory network genes","volume":"25","author":"Ara\u00fajo","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.omtn.2019.09.016_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.omtn.2019.09.016_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/322044","article-title":"Host-pathogen interactions: the attributes of virulence","volume":"184","author":"Casadevall","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtn.2019.09.016_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/EC.2.5.1053-1060.2003","article-title":"Engineered control of cell morphology in\u00a0vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection","volume":"2","author":"Saville","year":"2003","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.omtn.2019.09.016_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2011.10.048","article-title":"A recently evolved transcriptional network controls biofilm development in Candida albicans","volume":"148","author":"Nobile","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2019.09.016_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.cub.2005.05.047","article-title":"Regulation of cell-surface genes and biofilm formation by the C.\u00a0albicans transcription factor Bcr1p","volume":"15","author":"Nobile","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omtn.2019.09.016_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/mmi.12345","article-title":"The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosis","volume":"90","author":"Connolly","year":"2013","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.omtn.2019.09.016_bib13","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/emboj\/16.8.1982","article-title":"Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi","volume":"16","author":"Stoldt","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2019.09.016_bib14","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1099\/00221287-146-8-1763","article-title":"Transcription factors in Candida albicans \u2013 environmental control of morphogenesis","volume":"146","author":"Ernst","year":"2000","journal-title":"Microbiology"},{"key":"10.1016\/j.omtn.2019.09.016_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1574-6968.2002.tb11330.x","article-title":"The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans","volume":"214","author":"Ramage","year":"2002","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.omtn.2019.09.016_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","article-title":"Epidemiology of Candida species infections in critically ill non-immunosuppressed patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.omtn.2019.09.016_bib17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s10096-011-1455-z","article-title":"Insights into Candida tropicalis nosocomial infections and virulence factors","volume":"31","author":"Negri","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.omtn.2019.09.016_bib18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ijc.28704","article-title":"Antisense oligonucleotides against TNFR1 prevent toxicity of TNF\/IFN\u03b3 treatment in mouse tumor models","volume":"135","author":"Van Hauwermeiren","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2019.09.016_bib19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/039139880903200919","article-title":"Prospecting gene therapy of implant infections","volume":"32","author":"Costerton","year":"2009","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.omtn.2019.09.016_bib20","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/14728222.2015.1056155","article-title":"Therapeutic targets for the treatment of hepatitis E virus infection","volume":"19","author":"Kenney","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.omtn.2019.09.016_bib21","doi-asserted-by":"crossref","first-page":"e0004456","DOI":"10.1371\/journal.pntd.0004456","article-title":"Delayed time-to-treatment of an antisense morpholino oligomer is effective against lethal marburg virus infection in cynomolgus macaques","volume":"10","author":"Warren","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.omtn.2019.09.016_bib22","first-page":"900","article-title":"Inhibition of hepatitis B virus (HBV) replication using antisense LNA targeting to both S and C genes in HBV","volume":"17","author":"Deng","year":"2009","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.omtn.2019.09.016_bib23","series-title":"Methods and compositions for inhibition of RNA splicing","author":"Testa","year":"2000"},{"key":"10.1016\/j.omtn.2019.09.016_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mib.2016.05.017","article-title":"Antisense antimicrobial therapeutics","volume":"33","author":"Sully","year":"2016","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.omtn.2019.09.016_bib25","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.0337462100","article-title":"Uptake and antifungal activity of oligonucleotides in Candida albicans","volume":"100","author":"Disney","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.09.016_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1681.2006.04403.x","article-title":"Antisense oligonucleotides: from design to therapeutic application","volume":"33","author":"Chan","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.omtn.2019.09.016_bib27","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1046\/j.1432-1033.2003.03555.x","article-title":"Antisense technologies. Improvement through novel chemical modifications","volume":"270","author":"Kurreck","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.omtn.2019.09.016_bib28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2019.09.016_bib29","first-page":"347","article-title":"Antisense oligonucleotides: basic concepts and mechanisms","volume":"1","author":"Dias","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omtn.2019.09.016_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s13311-013-0194-5","article-title":"Antisense oligonucleotides: treating neurodegeneration at the level of RNA","volume":"10","author":"DeVos","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omtn.2019.09.016_bib31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ymthe.2017.03.023","article-title":"FDA-approved oligonucleotide therapies in 2017","volume":"25","author":"Stein","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.016_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1073\/pnas.75.1.280","article-title":"Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide","volume":"75","author":"Zamecnik","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.09.016_bib33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/9893","article-title":"Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A","volume":"17","author":"Mizuta","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2019.09.016_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7150\/ijms.2.50","article-title":"Epidemiology and prevention of hepatitis B virus infection","volume":"2","author":"Hou","year":"2005","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.omtn.2019.09.016_bib35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.virol.2005.08.034","article-title":"Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3\u2032 stem-loop structure","volume":"344","author":"Holden","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2019.09.016_bib36","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.2202","article-title":"Advanced antisense therapies for postexposure protection against lethal filovirus infections","volume":"16","author":"Warren","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.09.016_bib37","doi-asserted-by":"crossref","first-page":"10087","DOI":"10.4238\/2015.August.21.16","article-title":"Antiviral effect of hepatitis B virus S\/C gene loci antisense locked nucleic acid on transgenic mice in\u00a0vivo","volume":"14","author":"Deng","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.omtn.2019.09.016_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1358\/dnp.2010.23.5.1429489","article-title":"FtsZ inhibition: a promising approach for antistaphylococcal therapy","volume":"23","author":"Singh","year":"2010","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.omtn.2019.09.016_bib39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ijpharm.2013.05.041","article-title":"A peptide-morpholino oligomer conjugate targeting Staphylococcus aureus gyrA mRNA improves healing in an infected mouse cutaneous wound model","volume":"453","author":"Sawyer","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2019.09.016_bib40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1172\/JCI13885","article-title":"The experimental use of antisense oligonucleotides: a guide for the perplexed","volume":"108","author":"Stein","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2019.09.016_bib41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/jm00059a007","article-title":"Uniformly modified 2\u2032-deoxy-2\u2032-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets","volume":"36","author":"Kawasaki","year":"1993","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omtn.2019.09.016_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/oli.1.1996.6.169","article-title":"A simple method for delivering morpholino antisense oligos into the cytoplasm of cells","volume":"6","author":"Partridge","year":"1996","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.omtn.2019.09.016_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0165-6147(89)80004-5","article-title":"Designing antisense oligonucleotides as pharmaceutical agents","volume":"10","author":"Cohen","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.omtn.2019.09.016_bib44","doi-asserted-by":"crossref","first-page":"e14786","DOI":"10.1371\/journal.pone.0014786","article-title":"Discriminating multi-species populations in biofilms with peptide nucleic acid fluorescence in\u00a0situ hybridization (PNA FISH)","volume":"6","author":"Almeida","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.09.016_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbiotec.2016.03.047","article-title":"Optimization of peptide nucleic acid fluorescence in\u00a0situ hybridization (PNA-FISH) for the detection of bacteria: The effect of pH, dextran sulfate and probe concentration","volume":"226","author":"Rocha","year":"2016","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.omtn.2019.09.016_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/08927014.2015.1131821","article-title":"Discrimination of bacteriophage infected cells using locked nucleic acid fluorescent in situ hybridization (LNA-FISH)","volume":"32","author":"Vilas Boas","year":"2016","journal-title":"Biofouling"},{"key":"10.1016\/j.omtn.2019.09.016_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10544-017-0150-y","article-title":"Yeasts identification in microfluidic devices using peptide nucleic acid fluorescence in\u00a0situ hybridization (PNA-FISH)","volume":"19","author":"Ferreira","year":"2017","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.omtn.2019.09.016_bib48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5582\/ddt.2016.01065","article-title":"Drug delivery system of therapeutic oligonucleotides","volume":"10","author":"Asami","year":"2016","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.omtn.2019.09.016_bib49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/nat.2018.0727","article-title":"Intracellular trafficking and endosomal release of oligonucleotides: what we know and what we don\u2019t","volume":"28","author":"Juliano","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2019.09.016_bib50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/med.21479","article-title":"Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy","volume":"38","author":"Chen","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.omtn.2019.09.016_bib51","series-title":"ISO 10993-5:2009. Biological evaluation of medical devices. Part 5: tests for in\u00a0vitro cytotoxicity","year":"2009"},{"key":"10.1016\/j.omtn.2019.09.016_bib52","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1126\/science.7992058","article-title":"Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog","volume":"266","author":"Liu","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.omtn.2019.09.016_bib53","doi-asserted-by":"crossref","first-page":"0636","DOI":"10.1371\/journal.ppat.0020063","article-title":"Critical role of Bcr1-dependent adhesins in C.\u00a0albicans biofilm formation in\u00a0vitro and in\u00a0vivo","volume":"2","author":"Nobile","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2019.09.016_bib54","doi-asserted-by":"crossref","first-page":"397268","DOI":"10.1155\/2013\/397268","article-title":"Effect of Piper betle and Brucea javanica on the differential expression of hyphal wall protein (HWP1) in non-Candida albicans Candida (NCAC) species","volume":"2013","author":"Wan Harun","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.omtn.2019.09.016_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2014.03.003","article-title":"Impact of Candida albicans hyphal wall protein 1 (HWP1) genotype on biofilm production and fungal susceptibility to microglial cells","volume":"69-70","author":"Orsi","year":"2014","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.omtn.2019.09.016_bib56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/MMBR.00009-06","article-title":"Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans","volume":"71","author":"Biswas","year":"2007","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.omtn.2019.09.016_bib57","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrmicro2636","article-title":"Growth of Candida albicans hyphae","volume":"9","author":"Sudbery","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.omtn.2019.09.016_bib58","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI25424","article-title":"Antisense oligonucleotide therapy for neurodegenerative disease","volume":"116","author":"Smith","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"issue":"R1","key":"10.1016\/j.omtn.2019.09.016_bib59","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1093\/hmg\/ddv442","article-title":"Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington\u2019s disease and spinocerebellar ataxia","volume":"25","author":"Keiser","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.09.016_bib60","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1535-7163.MCT-18-0824","article-title":"Chemically modified antisense oligonucleotide against ARL4C inhibits primary and metastatic liver tumor growth","volume":"18","author":"Harada","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omtn.2019.09.016_bib61","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1038\/s41388-019-0696-7","article-title":"Suppression of prostate tumor cell survival by antisense oligonucleotide-mediated inhibition of AR-V7 mRNA synthesis","volume":"38","author":"Luna Velez","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2019.09.016_bib62","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0092-8674(00)80358-X","article-title":"Nonfilamentous C.\u00a0albicans mutants are avirulent","volume":"90","author":"Lo","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2019.09.016_bib63","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1042\/bst0240630","article-title":"Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitors","volume":"24","author":"Altmann","year":"1996","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.omtn.2019.09.016_bib64","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1093\/nar\/gkv920","article-title":"The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA","volume":"43","author":"Vickers","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.09.016_bib65","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1128\/AEM.02470-08","article-title":"Development and application of a novel peptide nucleic acid probe for the specific detection of Cronobacter genomospecies (Enterobacter sakazakii) in powdered infant formula","volume":"75","author":"Almeida","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.omtn.2019.09.016_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/08927014.2014.886108","article-title":"Effects of fluconazole on Candida glabrata biofilms and its relationship with ABC transporter gene expression","volume":"30","author":"Fonseca","year":"2014","journal-title":"Biofouling"},{"key":"10.1016\/j.omtn.2019.09.016_bib67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/genes9040205","article-title":"Portrait of matrix gene expression in Candida glabrata biofilms with stress induced by different drugs","volume":"9","author":"Rodrigues","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.omtn.2019.09.016_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2199-7-25","article-title":"Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR","volume":"7","author":"Nailis","year":"2006","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.omtn.2019.09.016_bib69","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/elps.201300148","article-title":"Challenging the limits of detection of sialylated Thomsen-Friedenreich antigens by in-gel deglycosylation and nano-LC-MALDI-TOF-MS","volume":"34","author":"Almeida","year":"2013","journal-title":"Electrophoresis"},{"key":"10.1016\/j.omtn.2019.09.016_bib70","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1074\/mcp.M200062-MCP200","article-title":"Sequential fractionation and two-dimensional gel analysis unravels the complexity of the dimorphic fungus Candida albicans cell wall proteome","volume":"1","author":"Pitarch","year":"2002","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.omtn.2019.09.016_bib71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u015bniewski","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2019.09.016_bib72","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.011015","article-title":"Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole orbitrap mass spectrometer","volume":"10","author":"Michalski","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.omtn.2019.09.016_bib73","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1099\/jmm.0.017517-0","article-title":"Silicone colonization by non-Candida albicans Candida species in the presence of urine","volume":"59","author":"Silva","year":"2010","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.omtn.2019.09.016_bib74","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/13693786.2012.700492","article-title":"The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic","volume":"51","author":"Silva","year":"2013","journal-title":"Med. Mycol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225311930263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225311930263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:40:02Z","timestamp":1784652002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225311930263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":74,"alternative-id":["S216225311930263X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2019.09.016","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of 2\u2032-OMethylRNA\u2032 Antisense Oligomer to Control Candida albicans EFG1 Virulence Determinant","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2019.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}